Jerusalem, Feb 3 (AFP/APP): Initial data from Israel’s closely-watched coronavirus vaccination campaign proves the Pfizer/BioNTech vaccine protects against serious illness but offers no conclusion yet on progress towards herd immunity, experts say.
The Jewish state is carrying out what is widely described as the world’s fastest vaccination campaign per capita. Many countries are struggling with vaccine supply but Israel has not experienced shortages since launching inoculations in December. It secured its substantial stock by paying above market price and, more importantly, through a data sharing agreement with Pfizer.
The agreement stipulates that Israel, which has one of the world’s most sophisticated medical data systems, will share real-time information with Pfizer on the vaccine’s impact, including on progress towards achieving herd immunity. So far, Israel has given the first of the two recommended Pfizer jabs to roughly 35 percent of its nine-million population. About 1.8 million have also received the second jab, mostly those over 60.
Kashmir Solidarity Day will be observed in a significant manner
Stay tuned to baaghi tv for latest news and updates!
